论文部分内容阅读
前言近年来,免疫学研究已证明,恶性肿瘤病人伴有细胞免疫功能的降低,而恶性肿瘤病人的细胞免疫机能状态又往往反映病情的严重程度和治愈的可能性。因此,在对恶性肿瘤病人作出诊断,制定治疗方案,以及判断预后等工作中,不仅要了解肿瘤本身的生物学特性及其发生发展对机体的影响,还必须了解机体细胞免疫力,进而分析肿瘤——宿主的相互关系。参加抗肿瘤免疫反应的细胞除巨噬细胞外,主要就是淋巴细胞,包括T细胞、K细胞(Killer Lymphocyte)和NK细胞(Nat-
Preface In recent years, immunological studies have shown that patients with malignant tumors accompanied by decreased cellular immune function, and cellular immune function of patients with malignant tumors often reflect the severity of the disease and the possibility of cure. Therefore, in the diagnosis of malignant tumor patients to develop treatment programs, and to determine the prognosis of work, not only to understand the biological characteristics of the tumor itself and its impact on the body’s development, but also must understand the body’s cellular immunity, and then analyze the tumor - the relationship between the host. In addition to macrophages, the cells that participate in the anti-tumor immune response are mainly lymphocytes including T cells, Killer Lymphocyte and NK-